VYNE Therapeutics Balance Sheet (2016-2025) | VYNE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter)	0.85M	118.52M	103.41M	52.31M	0.60M	50.49M	42.81M	35.51M	0.07M	30.21M	20.63M	15.45M	30.62M	19.07M	29.61M	0.05M	19.93M	28.21M	22.05M	24.03M
Short-term Investments (Quarter)	1.03M	1.03M											62.63M	66.89M	48.49M	53.91M	41.59M	22.06M	17.60M	4.98M
Cash & Current Investments (Quarter)	1.88M	119.54M	103.41M	52.31M	0.60M	50.49M	42.81M	35.51M	0.07M	30.21M	20.63M	15.45M	93.25M	85.95M	78.10M	53.96M	61.52M	50.27M	39.65M	29.01M
Receivables - Net (Quarter)	15.82M	10.76M	10.87M	10.08M	7.58M	0.54M	0.30M	0.47M	0.17M	0.10M	0.23M	0.25M
Receivables - Other (Quarter)	5.80M	8.10M	7.60M	7.30M	5.50M
Receivables (Quarter)	21.62M	18.86M	18.47M	17.38M	13.08M	0.54M	0.30M	0.47M	0.17M	0.10M	0.23M	0.25M
Raw Materials (Quarter)					3.30M
Finished Goods (Quarter)					4.00M
Inventory (Quarter)	7.40M	8.09M	8.28M	8.07M	7.29M
Prepaid Assets (Quarter)	4.59M	3.87M	5.27M	5.06M	4.57M	3.90M	3.77M	3.00M	2.30M	2.64M	2.02M	1.76M	2.66M	4.22M	5.63M	3.30M	2.92M	4.64M	4.70M	1.00M
Current Assets (Quarter)	87.26M	143.12M	128.43M	76.13M	63.19M	60.65M	51.92M	44.05M	38.27M	33.02M	22.96M	17.51M	95.96M	90.22M	83.78M	73.53M	64.44M	54.91M	44.34M	30.01M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.56M	0.53M	0.50M	0.47M	0.35M	0.31M	0.30M	0.13M									0.11M	0.11M	0.10M	0.09M
Long-Term Investments (Quarter)
Goodwill (Quarter)
Goodwill & Intangibles (Quarter)
Other Non-Current Assets (Quarter)	4.34M	0.85M	0.60M	0.60M	3.51M	0.60M		0.07M	0.10M	0.07M	0.07M	0.05M	0.05M	0.05M	2.72M	2.54M	2.26M	1.34M	0.24M	0.06M
Non-Current Assets (Quarter)	6.48M	6.05M	5.56M	5.19M	3.86M	3.67M	3.27M	2.86M	2.48M	2.24M	2.00M	1.76M	1.72M	1.45M	2.87M	2.66M	2.47M	1.51M	0.38M	0.15M
Assets (Quarter)	93.74M	149.17M	133.98M	81.31M	67.05M	64.32M	55.19M	46.91M	40.76M	35.26M	24.96M	19.27M	97.69M	91.68M	86.65M	76.20M	66.91M	56.42M	44.72M	30.16M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	4.78M	3.49M	10.08M	7.62M	6.51M	3.61M	1.43M	2.52M	2.39M	2.21M	1.16M	0.72M	1.66M	2.79M	4.52M	3.99M	2.71M	3.53M	1.41M	1.04M
Payables (Quarter)	4.78M	3.49M	10.08M	7.62M	6.51M	3.61M	1.43M	2.52M	2.39M	2.21M	1.16M	0.72M	1.66M	2.79M	4.52M	3.99M	2.71M	3.53M	1.41M	1.04M
Accumulated Expenses (Quarter)	11.45M	3.79M	10.15M	9.61M	2.75M	3.31M	1.60M	1.94M	4.38M	0.91M	0.84M	1.28M	1.65M	0.38M	0.74M	6.17M	1.43M	6.86M	0.82M	0.94M
Other Accumulated Expenses (Quarter)	0.10M	0.10M	0.10M	0.10M											1.31M	1.31M	1.31M	1.31M
Short term Debt (Quarter)			33.38M
Current Leases (Quarter)	0.76M	0.65M	0.43M	0.28M	0.35M	0.12M	0.03M						0.12M	0.12M	0.12M	0.12M	0.10M	0.06M	0.03M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	21.77M	21.55M	57.62M	21.00M	18.41M				9.35M	7.52M	6.37M	6.45M	7.54M	6.93M	11.75M	12.66M	14.82M	12.29M	5.84M	2.40M
Non-Current Liabilities
Non-Current Debt (Quarter)	33.17M	33.27M
Non-Current Deffered Revenue (Quarter)
Preferred Stock Liabilities (Quarter)
Minority Interest (Quarter)									0.21M
Operating Leases (Quarter)	1.61M	1.43M	0.81M	1.05M	0.35M								0.21M	0.06M	0.03M		0.10M
Other Non-Current Liabilities (Quarter)	0.31M	0.46M	0.21M	0.45M	0.21M	0.22M	0.26M	0.21M		1.30M	1.31M	1.31M	1.31M	1.31M
Total Non-Current Liabilities (Quarter)	34.48M	55.81M	58.88M	21.98M		8.37M	6.58M	6.63M		7.53M	6.37M	6.45M	1.41M	1.38M	0.03M
Total Liabilities (Quarter)	56.25M	56.27M	59.09M	22.43M	18.41M	8.59M	6.83M	6.84M	9.35M	8.83M	7.69M	7.76M	8.95M	8.31M	11.78M	12.66M	14.82M	12.29M	5.84M	2.40M
Shareholder's Equity
Total Debt (Quarter)	33.17M	33.27M	33.38M
Common Equity (Quarter)	37.49M	92.90M	74.89M	58.89M	48.64M	55.73M	48.36M	40.07M	31.20M	26.43M	17.27M	11.51M	88.73M	83.37M	74.87M	63.54M	52.09M	44.13M	38.88M	27.77M
Shareholder's Equity (Quarter)	37.49M	92.90M	74.89M	58.89M	48.64M	55.73M	48.36M	40.07M	31.20M	26.43M	17.27M	11.51M	88.73M	83.37M	74.87M	63.54M	52.09M	44.13M	38.88M	27.77M
Liabilities and Shareholders Equity (Quarter)	93.74M	149.17M	133.98M	81.31M	67.05M	64.32M	55.19M	46.91M	40.76M	35.26M	24.96M	19.27M	97.69M	91.68M	86.65M	76.20M	66.91M	56.42M	44.72M	30.16M
Retained Earnings (Quarter)		-586.75M	-606.67M	-628.00M	-639.52M	-634.90M	-643.30M	-652.79M	-662.74M	-668.51M	-678.60M	-685.10M	0.03M	-697.60M	-0.06M	0.03M	0.02M	-739.80M	-745.54M	-757.70M
Treasury Shares (Quarter)	0.72M				0.07M				0.08M				0.46M				0.75M			0.45M

Research Tools

VYNE Therapeutics Balance Sheet (2016-2025) | VYNE

Create an account

Sign In

Reset Password